Legal & General Group
EVMN

Legal & General Group’s Evommune Inc EVMN Stock Holding History

Legal & General Group’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1K Buy
919
+519
+130% +$11.7K ﹤0.01% 2946
2025
Q4 		$6.85K Buy
+400
New +$7.51K ﹤0.01% 3314

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $1.02B AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Legal & General Group's EVMN Position: Q1 2026 in Review

Legal & General Group increased its Evommune Inc (EVMN) stake by 130% in Q1 2026, buying an estimated $11.7K and bringing the position to 919 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Legal & General Group first reported a position in EVMN in Q4 2025 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold EVMN as of Q1 2026.

  • Legal & General Group held 919 shares of Evommune Inc worth $21.1K as of Q1 2026.
  • Legal & General Group bought 519 Evommune Inc shares in Q1 2026, an estimated $11.7K.
  • Evommune Inc made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2946 holding.
  • Legal & General Group first reported a position in Evommune Inc in Q4 2025 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Evommune Inc as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.